Surgical Automations

Executive Summary

Surgical Automations is a San Diego-based private medical device company developing the Vāsuki Robotic System, an autonomous endoscopic robotic platform designed to enhance precision and control in minimally invasive procedures. Founded in 2017, the company leverages advanced AI and precision engineering to empower physicians with superior navigation and autonomy during endoscopy. Currently in a pre-launch development phase, Surgical Automations aims to address the growing demand for robotic-assisted surgery in gastroenterology, urology, and other endoscopic specialties. The Vāsuki system differentiates itself through partial autonomy, potentially reducing procedure time and variability while improving outcomes. With a strong intellectual property portfolio and a focus on clinical validation, the company is positioned to disrupt the endoscopic robotics market, which is projected to exceed $5 billion by 2030. Key near-term milestones include completing preclinical studies, initiating first-in-human trials, and securing FDA clearance. The company's progress will depend on successful capital raises and partnership development to support regulatory and commercial pathways.

Upcoming Catalysts (preview)

• Q4 2026First-in-human clinical trial initiation for Vāsuki Robotic System60% success
• Q3 2026FDA Breakthrough Device designation70% success
• Q2 2026Series A funding round closure ($10-20M)65% success